Despite a comparatively small population by European standards, Ireland's macroeconomic indicators remain healthy, with strong GDP growth rates. IRELAND_GRAPH13
Ireland is globally competitive in terms of flexibility, adaptability, human resources, culture, and economic policy. IRELAND_GRAPH02
Ireland's tax regime is also globally competitive, with favourable corporate tax rates, R&D tax credit, and an excellent IP tax regime. IRELAND_GRAPH14
Compared to other pharma powerhouses across Europe and the world, Ireland's corporate tax rates are comparatively low and extremely favourable to investors. IRELAND_GRAPH15
After taking a hit following the financial crisis and subsequent slump, Ireland's economy is well on the road to recovery with year on year PPP GDP growth since 2012. IRELAND_GRAPH04
Along with GDP growth, Ireland's unemployment rate has steadily been decreasing since 2012. IRELAND_GRAPH06
Top 10 Pharmaceutical Employers in Europe: Ireland punching above its weight. IRELAND_GRAPH03
Top 10 Pharmaceutical Producers in Europe: Ireland number five, ahead of the UK! IRELAND_GRAPH05
In 2015, Ireland exported more pharmaceuticals than ever before (EUR 30.2 billion), while also importing more (EUR 5.7 billion). IRELAND_GRAPH11
Ireland's biopharma industry is a major employer, revenue generator and exporter, and is set to grow more with further investments slated for the coming years. IRELAND_GRAPH10
Mapping Irish Biopharma: Dublin and Cork are the two most important biopharma clusters in Ireland. IRELAND_GRAPH07
Key indicators for healthcare in Ireland. IRELAND_GRAPH12
Ireland has the highest percentage of its population under 25 years old in Europe (33.3 percent). IRELAND_GRAPH09
Ireland's epidemiological profile with the major causes of death and prevalent health conditions. IRELAND_GRAPH08